Search results
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 3 days agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022....
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 2 days agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 2 days agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials
Investing.com· 3 days agoVaxart, Inc. (NASDAQ: NASDAQ: VXRT ), a biotechnology company specializing in the development of...
7 Cheap Value Stocks to Buy Now: May 2024
InvestorPlace· 20 hours agoThe major stock market indexes are near record highs. The good news, however, is that investors can still put money to work in today’s market without...
Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal
The Wall Street Journal· 6 days agoNovavax shares (NVAX) surged after the vaccine maker said it had struck a licensing deal worth up to...
Cancer Vaccine Triggers Fierce Immune Response to Fight Malignant Brain Tumors in Human Patients
GoodNewsNetwork· 5 days agoThe discovery represents a potential new way to recruit the immune system to fight...
Countries struggle to draft 'pandemic treaty' to avoid mistakes made during COVID
San Francisco Chronicle· 6 days agoAfter the coronavirus pandemic triggered once-unthinkable lockdowns, upended economies and killed...
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
AOL· 5 days agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine giant Sanofi (SNY) would invest $1.2 billion in a deal for Novavax's
Novavax's Q1 Results Are Overshadowed by Its Sanofi Partnership | The Motley Fool
The Motley Fool· 3 days agoNovavax (NVAX 47.63%) released its first-quarter earnings report on May 10, and the vaccine-focused biotechnology company's numbers reflected notable progress. Novavax brings ...